Vicore Pharma Holding AB (publ) (VICO) — Cash Flow-to-Debt Ratio
Vicore Pharma Holding AB (publ) (VICO) has a Cash Flow-to-Debt Ratio of -0.66x as of December 2025, meaning its operating cash flow of Skr-81.48 Million could theoretically repay -1% of its total liabilities (Skr124.16 Million) in one year. Check Vicore Pharma Holding AB (publ) (VICO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vicore Pharma Holding AB (publ) Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Vicore Pharma Holding AB (publ) across 14 annual periods. Also explore VICO total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Vicore Pharma Holding AB (publ) (2012–2025)
Year-by-year debt coverage analysis for Vicore Pharma Holding AB (publ). For market capitalisation and broader financial context, see Vicore Pharma Holding AB (publ) market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.02x | Skr-374.44 Million | Skr124.16 Million | ▼ -34.9% |
| 2024 | -2.24x | Skr-164.95 Million | Skr73.78 Million | ▲ +62.0% |
| 2023 | -5.88x | Skr-249.58 Million | Skr42.45 Million | ▲ +4.1% |
| 2022 | -6.13x | Skr-299.92 Million | Skr48.92 Million | ▼ -56.9% |
| 2021 | -3.91x | Skr-265.17 Million | Skr67.85 Million | ▼ -69.4% |
| 2020 | -2.31x | Skr-119.94 Million | Skr52.00 Million | ▲ +48.3% |
| 2019 | -4.46x | Skr-87.00 Million | Skr19.51 Million | ▼ -118.2% |
| 2018 | -2.04x | Skr-33.04 Million | Skr16.16 Million | ▼ -74.0% |
| 2017 | -1.17x | Skr-7.71 Million | Skr6.56 Million | ▲ +1.9% |
| 2016 | -1.20x | Skr-7.25 Million | Skr6.05 Million | ▼ -137.3% |
| 2015 | -0.50x | Skr-3.68 Million | Skr7.29 Million | ▼ -1.3% |
| 2014 | -0.50x | Skr-2.83 Million | Skr5.67 Million | ▼ -204.8% |
| 2013 | -0.16x | Skr-1.79 Million | Skr10.97 Million | ▼ -18.4% |
| 2012 | -0.14x | Skr-1.67K | Skr12.09K | — |